Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: A review of the literature
PT-141, also known as Bremelanotide, takes a very different approach
Real-Time Trafficking and Signaling of the Glucagon-Like Peptide-1 Receptor
Kitada M, Ogura Y, Monno I, Xu J, Koya D
The relatively simple cases of products that PBMs have excluded from formulary altogether, including weight loss therapeutics, belie the complexities of what it means when you do see products on formulary
Its one thing to say that, theoretically, GLP-1s should help make everyones body a little healthier and therefore help them live longer, or that these drugs can stop serious health conditions before they start